Australian (ASX) Stock Market Forum

CCO - The Calmer Co International

Joined
27 June 2010
Posts
4,147
Reactions
309
The Fiji Kava Group is primarily a biotechnology company whose research and development aspirations are underpinned with an existing business selling kava extracts as a consumer product.

The Company considers that the scale-up and improvement of the underlying kava retail business will be synergistic to the development of additional products and intellectual property from kavalactone research.

The key business objectives of the Company on completion of the IPO are:
  • human clinical trials to be developed in consultation with the National Institute of Complementary Medicine (NICM) and the Scientific Advisory Board in order to establish the efficacy and safety of the Company's products, and to develop novel kava extracts and kava combination products. This research is slated to commence in the fourth quarter of 2018;
  • the primary production of mkava through a network of outsourced kava farms and via its own Farm located in Fiji; and
  • the production and sale of kava supplements and complimentary medicines.
It is anticipated that FIJ will list on the ASX during November 2018.

https://fijikava.com/
 
Like Cannabis/Weed I think Kava is going to catch on in time...

It's the only Kava stock listed, so unlike the dozens of Weed stocks that are growing amongst the ASX garden beds, if there is a frenzy into Kava and it's health benefits this stock should do well, hence picked for CY2021 competition...

1609680429107.png
 
Fiji Kava's "Noble Kava" range of products to be stocked in Australian Chemist Warehouse stores beginning this month:

7 April 2021, Brisbane Australia - Fiji Kava Ltd (ASX: FIJ), an Australian-Fijian medicinal kava health and wellness company which produces natural ‘Noble Kava’ products for the complementary and alternative medicine market, today announces ranging in Australia's largest pharmacy retailer, Chemist Warehouse.

The agreement will see Fiji Kava's suite of Noble Kava™ 60 vegan capsules including Noble Kava™ Extract, Noble Sleep™, Noble Calm™ and Noble Body™, be merchandised in Chemist Warehouse's Australia and New Zealand network of more than 300 retail stores and Chemist Warehouse online.

To coincide with the announcement, Fiji Kava confirms receipt of the initial purchase order from Chemist Warehouse for fulfillment, enabling the anticipated rollout and merchandising of Fiji Kava Noble Kava™ capsule range in Chemist Warehouse stores nationally throughout April and May.

This is a key milestone for Fiji Kava with the pharmacy network being the single largest domestic channel for Australian consumers purchasing complementary and alternative medicines1; with 45% of people buying vitamins, minerals or supplements going to Chemist Warehouse2.
 

Completes Purchase of Danodan​


• FijiKava Inc. USA has completed the acquisition of Danodan Hempworks LLC
• The acquisition includes Danodan’s Portland Oregon based CBD Tincture Plant, Inventory
and all associated intellectual property, CBD extract US Patent 10,716,819
• FijiKava’s US subsidiary. FijiKava Inc (USA) began doing business as The Calmer Co. USA
from January 1st 2022
• The existing Danodan team, including founder Danial Stoops have joined The Calmer Co.
• Global CBD market valued at USD 2.8 billion in 2020 and is expected to grow at a compound
annual growth rate (CAGR) of 21.2% through to 20281
19 January 2022 Portland Oregon USA - FijiKava Ltd (ASX: FIJ), an Australian-Fijian medicinal kava
company which produces natural products to reduce anxiety, promote relaxation, improve sleep and
support sports recovery and performance, has completed the acquisition of Danodan Hempworks LLC,
including its CBD extraction US Patent 10,716,819, purchased from Danodan Founder, Mr Daniel Stoops
(together, “Danodan”).
Danodan produces a suite of organic certified CBD tincture products sold throughout wellness boutiques
and regional natural foods grocery stores in the USA. FijiKava has begun work on scoping the use of
Danodan’s patented extraction process for Noble Kava products.
To reflect its expanded product lines and plans for further acquisitions of aligned brands and products,
FijiKava Inc. (USA) is now doing business as The Calmer Co. (USA) as of 1
st January 2022.
Daniel Stoops, Founder of Danodan said “We're really excited about this opportunity. We've been
looking for a new relationship like this. We’re aligned on values. We fit very nicely into The Calmer Co
(USA)’s mission. Our products are all about reducing anxiety, relaxation, and better sleep. With the
combination of investment and sales and marketing expertise of the new team, the Danodan brand has
a bright future”
Fiji Kava CEO, Anthony Noble said: "FijiKava Inc (USA) has now commenced US operations on the
ground as The Calmer Co. (USA). We are gathering a group of likeminded brands and companies,
focussed on delivering customers the world’s leading suite of products to reduce anxiety, promote
relaxation, improve sleep and support sports recovery and performance and this acquisition is the first
step in executing that vision.
1. Cannabidiol Market Size, Share & Trends Analysis Report By Source Type (Hemp, Marijuana), By Distribution Channel (B2B, B2C), By End-use
(Medical, Personal Use), By Region, And Segment Forecasts, 2021 – 2028. Grand View Research.
Danodan’s organic certified CBD tinctures are renowned in the USA for purity and quality and
represent an integrative, broad-spectrum approach to herbal formulation, with a real point of difference
from highly processed CBD products. The global CBD market exceeds US$2.8bn1 and leading the way
is the US market, which is becoming increasingly mainstream. Recent progress such as California
Assembly Bill 45 demonstrate this. Growing the availability of the Danodan products in retail and online
will be a key initial driver of growth for of the Danodan products, as it has been for FijiKava products.
“The liquid dispersible beverage ready format of these tinctures is highly aligned with our growing
innovation and product development pipeline; including the exploration of kava and CBD combination
products in the OTC, dietary supplement and functional beverage markets.”
FijiKava Inc. (USA) has acquired Danodan Hempworks LLC, the associated production plant and
equipment, inventory, raw materials trademarks and other IP and marketing collateral for USD235,000
and has assumed a 30-year loan valued at USD150,000 from the US Small Business Administration.
FijiKava Ltd has acquired US Patent 10,716,819 for USD225,000. In addition, Mr Stoops will receive
10% equity in Danodan Hempworks LLC. Taken together, these amounts will constitute full
consideration for the transaction.
There have been no changes in the FijiKava Ltd Board of Directors or senior management team due to
this acquisition.
This release has been approved by the Board of Directors
ENDS


===================================================================================

DYOR

i hold FIJ

am not so sure on this .. CBD based in Oregon ( Antifa US HQ ) maybe the patent they bought is the silver lining ( MIGHT be useful on Kava as well )
 
• Coles has commenced ranging FijiKava’s Drinking Kava nationally in more than 700 locations in Australia this week
• Coles will stock their 50g FijiKava Instant Kava product alongside their Noble Kava extract capsules and three Noble Kava® medicinal product varieties; Noble Sleep®, Noble Calm® and Noble Body ®
• FijiKava is the only nationally distributed Drinking Kava product
• Coles is Australia’s second largest supermarket chain, accounting for 27% of retail sales in Australia 16 February 2022 Brisbane Australia - Fiji Kava Ltd (ASX: FIJ), an Australian-Fijian medicinal kava health and wellness company which produces natural products for the complementary medicine market, has today announced that their 50g Drinking Kava product which will be ranged in more than 700 Coles stores across all states in Australia, excluding the Northern Territory.
Australia announced a pilot importation program for drinking kava in December 2021, and the product can now legally be sold for the first time in almost 15 years. Drinking kava is the traditional kava format used widely around the Pacific as a recreational beverage.
Fiji Kava Ltd is the only foreign company licensed by the Fijian Government to operate in the kava industry.
Fiji Kava CEO, Anthony Noble said: “National distribution of our Drinking Kava through Coles is a critical step forward to increase the availability of Noble Fijian Kava for Australian consumers.
Fiji Kava’s range of complementary medicine products has been on sales through Coles for the last 20 months, and we have invested in making consumers aware of the health benefits of these products for sleep, stress relief and muscle relaxation.
We believe this new product format will allow more consumers to experience kava at an extremely competitive price point." “In the USA market drinking kava sales significantly outstrip capsule and tablet sales and there is no reason to think that in Australia a similarly strong demand will be seen.
Our products are all produced utilising Good Manufacturing Practices in HACCP accredited facilities and only utilising the safest and most effective subset of Noble Fijian Kava varieties. This ensures our products are entirely safe and deliver reliable benefits to consumers.”

DYOR

i hold FIJ ( at full-cash risk ) and COL ( courtesy of the WES demerger )

MAYBE it will bump the share price ( i bought in @ 7.4 cents )

maybe they should send shareholders product instead of divs. LOL
 

Fiji Kava (ASX:FIJ) strikes Taki Mai distribution deal with CJ Patel​


The distribution agreement comes with a minimum sales target of $11 million over its initial three-year term, which CJ Patel needs to hit in order to retain its exclusivity over the product range.

Fiji Kava said CJ Patel was the largest distribution company in the South Pacific, representing some of the world’s best-known FMCG (fast-moving consumer goods) brands.

The 17 countries covered under today’s deal represent a sizeable chunk of FIJ’s target market, including Australia, New Zealand, Samoa, Tonga, Papua New Guinea, and East Timor.

Live charts: https://uk.advfn.com/p.php?pid=staticchart&s=ASX^FIJ&p=0&t=1
 
On April 21st, 2023, Fiji Kava Limited (FIJ) changed its name and ASX code to The Calmer Co International Limited (CCO).
 
The Calmer Co. International Limited (ASX:CCO) announced the launch of its new e-commerce store in the United States for its FijiKava® brand.

CEO Anthony Noble commented, “Seeing the FijiKava® range growing at circa 20% quarter on quarter since 2022, underlines why we will now focus on e-commerce, which has lower and more scalable cost to service versus conventional retail channels.”

Shares are trading at 0.3 cents.

Well, good luck with that
collect
.
 
April Sales Update on eCommerce and Coles
15 May 2024

Brisbane, Australia: The Calmer Co. International Limited (ASX:CCO), a health and wellness company focussing on natural products that promote calmness, support relaxation and improve sleep informs shareholders that April ecommerce sales have continued to grow strongly and have now suprassed $11k per day and provides an update on the initial 8 weeks post launch, of retails sales to Coles Australia of the Taki Mai kava shots, 150g FijiKava Instant Kava and restock of 50g FijiKava Instant Kava.

Highlights
• Coles scan sales over the initial launch period exceed $150k and were running at over $30k per week and >4600 units per week, in week 8 after launch (5th -11th May).
• eCommerce Sales continue to grow month-on-month and now exceed $11,000 per day

CEO Anthony Noble said, “Excellence in ecommerce is our primary growth pillar. We have continued to grow month-on-month in these channels, with both Shopify and Amazon contributing.

Shopify USA sales in April were more than 4x the March baseline indicating that our strategy in the USA is showing similar promising signs to the early days in the Australian market for Shopify.”

“Profitable Retail is our second growth pillar and Coles Australia has been our primary partner in this channel. The initial sales results seen for the new range of three products in Coles are extremely promising and this is now backed up by scan data showing a rapid acceleration in both value of retail sales and units sold across the discount cycle in Coles.”

“The company will continue to focus on the most profitable and sustainable sales channels over the coming year.” This announcement has been approved by the board of directors

i hold CCO ( deeply underwater )

please be careful , there is a market saturation point out there somewhere ( is it before they start making a profit or after )

stressed consumers and rising costs will eat into increasing sales
 
and with an investor presentation out, went for a run yesterday, but coming down off the high rather abruptly

Screenshot_20240606-164408_CommSec.jpg

.
Screenshot_20240606-164705_Drive.jpg
Screenshot_20240606-164705_Drive~2.jpg
 
The typo is atrocious "$16,0000/day" not sure how that got missed
hardly anybody 'proof-reads ' even at professional media outlets

i remember working at one and management would regularly ( more than twice a year ) come to my team and complain about obvious errors .. much to the team's amusement ... because the print run would finish two hours before we would even glance at the front page ( and we didn't have time to read it anyway )

what the heck were we going to do use a textra correcting 200,000 plus copies , and then send them out ( the team normally had six workers ) and by the way they often spat out 10 editions a night ( some vastly different to the earlier runs )

and YES some goofs were biggies including letters from lawyers threatening to sue ( others demanding a discount/refund )
 
Top